Medications designed to promote weight loss by mimicking GLP-1 may also help limit additional heart damage after a heart attack. A new study led by researchers at the University of Bristol and University College London (UCL) found that these…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply